Skip to Main Content
Table 3

IL-12 and IFN-γ Synthesis by Cells Harvested from iNOS ko and C57BL/6 Mice at 5 d after i.p. Challenge with T. gondii

Peritoneal exudateSpleenSerum
Mean ± SE nRangeMean ± SEnRangeMean ± SEnRange
IL-12p40  C57BL/6  bkg     1.4 ± 0.5        0–3.5     5.4 ± 1.8    2.3–12.7  17.1 ± 3.9   15.6–23.2 
    STAg    10.9 ± 3.3   0.3–19.5  35.4 ± 6.0   20.7–53.5       
  iNOS ko  bkg     1.9 ± 0.4    1.2–4.1  10.3 ± 2.8    3.6–17.6    19.5 ± 9   13.7–27.3 
    STAg    11.9 ± 4.3   4.3 ± 25.9  56.4 ± 9.1   38.0–93.6       
                       
IFN-γ  C57BL/6  bkg     0.1 ± 0.06      0–0.3     0.6 ± 0.5        0–3.1   5.1 ± 0.5   4.4–5.8 
    STAg   1.0 ± 0.3    0.2–2.1     8.3 ± 2.1    1.3–17.9       
  iNOS ko  bkg   6.0 ± 2.9   0.3–15.4     1.1 ± 0.7        0–3.9   3.4 ± 0.3   2.9–3.8 
    STAg   8.2 ± 4.0   0.8–2.13  10.4 ± 2.7    1.8–19.2       
Peritoneal exudateSpleenSerum
Mean ± SE nRangeMean ± SEnRangeMean ± SEnRange
IL-12p40  C57BL/6  bkg     1.4 ± 0.5        0–3.5     5.4 ± 1.8    2.3–12.7  17.1 ± 3.9   15.6–23.2 
    STAg    10.9 ± 3.3   0.3–19.5  35.4 ± 6.0   20.7–53.5       
  iNOS ko  bkg     1.9 ± 0.4    1.2–4.1  10.3 ± 2.8    3.6–17.6    19.5 ± 9   13.7–27.3 
    STAg    11.9 ± 4.3   4.3 ± 25.9  56.4 ± 9.1   38.0–93.6       
                       
IFN-γ  C57BL/6  bkg     0.1 ± 0.06      0–0.3     0.6 ± 0.5        0–3.1   5.1 ± 0.5   4.4–5.8 
    STAg   1.0 ± 0.3    0.2–2.1     8.3 ± 2.1    1.3–17.9       
  iNOS ko  bkg   6.0 ± 2.9   0.3–15.4     1.1 ± 0.7        0–3.9   3.4 ± 0.3   2.9–3.8 
    STAg   8.2 ± 4.0   0.8–2.13  10.4 ± 2.7    1.8–19.2       

Mice were infected with 20 ME49 cysts each, killed 5 d later, and then peritoneal and spleen cells were isolated. Cell suspensions from each animal were cultured for 72 h in medium alone or in the presence of STAG (5 μg/ml). Supernatants were then assayed by ELISA for IL-12p40 and IFN-γ as described in Materials and Methods. The data shown are pooled from three experiments employing the number of animals indicated.  

Close Modal

or Create an Account

Close Modal
Close Modal